Navigating End of Life Challenges in Lewy Body Dementia (LBD)

Individuals with Lewy body dementia (LBD) have a unique symptom profile which may impact end of life experiences. Hallucinations, paranoia, cognitive fluctuations, movement changes, and sensitivity to antipsychotic medications raise unique challenges for navigating end of life with LBD. 

Join us for this special presentation by Dr. Melissa J. Armstrong, from LBDA’s Research Center of Excellence at the University of Florida, Gainesville. Dr. Armstrong has a clinical and research interest in better understanding the moderate to advanced stages of dementia with Lewy bodies (DLB).  

By the completion of this presentation, you will be able to: 

1. Describe the unique challenges at the end of life for people living with LBD and their care partners. 
2. Highlight various strategies for coping with and planning for end of life with LBD. 
3. Identify sources of support for navigating the challenges at end of life with LBD. 

About Melissa Armstrong, MD, MSc 

Melissa Armstrong, MD, MSc directs the University of Florida Health Mangurian Clinical-Research Headquarters for Lewy Body Dementia, one of the LBDA Research Centers of Excellence. This clinic is located at the Norman Fixel Institute for Neurological Diseases. Dr. Armstrong’s LBD Life Lab has funding from the National Institutes of Health (NIH) and the Florida Department of Health. Her research focuses on the lived experiences of people with Lewy body dementia and their families, including in the moderate-advanced stages.  

Register Now: https://events.zoom.us/ev/AiFRlspqbe9s3smbdtbsNfR5dhy8QlQmrWzGyJtGk_ZzdBgYCfYH~AkOBKMlb3D189SLCKaEAwqhTflLDsyP2mpM4bIAFvBFcuRdXfCWlYebRaA 

For questions or more information, please contact Rose Heithoff, Education Coordinator, at rheithoff@lbda.org.